VBIO
Price:
$0.2925
Market Cap:
$95.66M
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Industry
Biotechnology
IPO Date
2021-11-11
Stock Exchange
NASDAQ
Ticker
VBIO
According to Valion Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.13. This represents a change of -97.00% compared to the average of -4.34 of the last 4 quarters.
The mean historical PE Ratio of Valion Bio, Inc. over the last ten years is -5.86. The current -0.13 PE Ratio has changed 121.71% with respect to the historical average. Over the past ten years (40 quarters), VBIO's PE Ratio was at its highest in in the June 2023 quarter at 80.00. The PE Ratio was at its lowest in in the December 2023 quarter at -81.88.
Average
-5.86
Median
-3.73
Minimum
-35.00
Maximum
10.92
Discovering the peaks and valleys of Valion Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.30%
Maximum Annual PE Ratio = 10.92
Minimum Annual Increase = -221.30%
Minimum Annual PE Ratio = -35.00
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 0.84 | -136.19% |
| 2024 | -2.33 | -121.37% |
| 2023 | 10.92 | -221.30% |
| 2022 | -9.00 | 0% |
| 2021 | -9.00 | 2.30% |
| 2020 | -0.38 | -54.25% |
| 2019 | -0.82 | -90.62% |
| 2018 | -8.74 | 70.26% |
| 2017 | -5.13 | -85.34% |
| 2016 | -35.00 | 452.63% |
The current PE Ratio of Valion Bio, Inc. (VBIO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.14
5-year avg
-1.71
10-year avg
-5.86
Valion Bio, Inc.’s PE Ratio is greater than Organicell Regenerative Medicine, Inc. (-4.73), greater than OptiBiotix Health Plc (-1.52), greater than Kadimastem Ltd (-3.00), greater than OKYO Pharma Limited (-6.57), greater than Vinergy Capital Inc. (-10.10), less than Sorrento Therapeutics, Inc. (-0.00), less than American Hemp Ventures, Inc. (0), less than Antisense Therapeutics Limited (0), less than TPCO Holding Corp. (-0.07), greater than Biofrontera AG (-1.11),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.73 | $19.97M | |
| -1.52 | $20.06M | |
| -3.00 | $9.50M | |
| -6.57 | $22.73M | |
| -10.10 | $20.57M | |
| -0.00 | $16.54M | |
| 0 | $16.47M | |
| 0 | $19.64M | |
| -0.07 | $20.12M | |
| -1.11 | $19.35M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valion Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Valion Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Valion Bio, Inc.'s PE Ratio?
How is the PE Ratio calculated for Valion Bio, Inc. (VBIO)?
What is the highest PE Ratio for Valion Bio, Inc. (VBIO)?
What is the 3-year average PE Ratio for Valion Bio, Inc. (VBIO)?
What is the 5-year average PE Ratio for Valion Bio, Inc. (VBIO)?
How does the current PE Ratio for Valion Bio, Inc. (VBIO) compare to its historical average?